Impact of ruxolitinib pretreatment on outcomes after allogeneic stem cell transplantation in patients with myelofibrosis

Is allogeneic stem cell transplantation for myelofibrosis still indicated at the time of molecular markers and JAK inhibitors era?

(2017) Elsa Lestang et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial

(2017) Srdan Verstovsek et al.   Journal of Hematology & Oncology

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors

(2016) Mohamed Shanavas et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis

(2016) H Alchalby et al.   BONE MARROW TRANSPLANTATION

Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis

(2016) C N Harrison et al.   LEUKEMIA

Myelofibrosis: to transplant or not to transplant?

(2016) R. Devlin et al.   Hematology-American Society of Hematology Education Program

Allogeneic Hematopoietic Stem-Cell Transplantation for Myelofibrosis: A Practical Review

(2016) Nosha Farhadfar et al.   Journal of Oncology Practice

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report

(2015) Madan H. Jagasia et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Allo-SCT for myelofibrosis: reversing the chronic phase in the JAK inhibitor era?

(2015) R Tamari et al.   BONE MARROW TRANSPLANTATION

Pathogenesis of myeloproliferative neoplasms

(2015) Radek C. Skoda et al.   EXPERIMENTAL HEMATOLOGY

Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I

(2015) S. Verstovsek et al.   HAEMATOLOGICA

Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group

(2015) N M Kröger et al.   LEUKEMIA

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

(2015) R Zeiser et al.   LEUKEMIA

Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I

(2015) S. Verstovsek et al.   HAEMATOLOGICA

Allogeneic Stem Cell Transplant vs. Janus Kinase Inhibition in the Treatment of Primary Myelofibrosis or Myelofibrosis After Essential Thrombocythemia or Polycythemia Vera

(2014) Haefaa Alchalby et al.   Clinical Lymphoma Myeloma & Leukemia

Allogeneic hematopoietic stem cell transplantation in patients with polycythemia vera or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia: a report from the MPN Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation

(2014) F. Lussana et al.   HAEMATOLOGICA

JAK inhibition with ruxolitinib as pretreatment for allogeneic stem cell transplantation in primary or post-ET/PV myelofibrosis

(2014) T Stübig et al.   LEUKEMIA

CD34+-Selected Stem Cell Boost without Further Conditioning for Poor Graft Function after Allogeneic Stem Cell Transplantation in Patients with Hematological Malignancies

(2013) Evgeny Klyuchnikov et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Reduced-Intensity Hematopoietic Cell Transplantation for Patients with Primary Myelofibrosis: A Cohort Analysis from the Center for International Blood and Marrow Transplant Research

(2013) Vikas Gupta et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Three-year efficacy, safety, and survival findings from COMFORT-II, a phase 3 study comparing ruxolitinib with best available therapy for myelofibrosis

(2013) F. Cervantes et al.   BLOOD

The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo

(2013) A. Heine et al.   BLOOD

Ruxolitinib is a potent immunosuppressive compound: is it time for anti-infective prophylaxis?

(2013) A. Heine et al.   BLOOD

Allogeneic hematopoietic cell transplantation for myelofibrosis in patients pretreated with the JAK1 and JAK2 inhibitor ruxolitinib

(2013) N Jaekel et al.   BONE MARROW TRANSPLANTATION

Effect of Ruxolitinib Therapy on Myelofibrosis-Related Symptoms and Other Patient-Reported Outcomes in COMFORT-I: A Randomized, Double-Blind, Placebo-Controlled Trial

(2013) Ruben A. Mesa et al.   JOURNAL OF CLINICAL ONCOLOGY

Allogeneic hematopoietic cell transplantation for myelofibrosis in the era of JAK inhibitors

(2012) V. Gupta et al.   BLOOD

Effects of spleen status on early outcomes after hematopoietic cell transplantation

(2012) G Akpek et al.   BONE MARROW TRANSPLANTATION

Allogeneic Stem Cell Transplantation for Myelofibrosis in 2012

(2012) Donal P. McLornan et al.   BRITISH JOURNAL OF HAEMATOLOGY

Improving Survival Trends in Primary Myelofibrosis: An International Study

(2012) Francisco Cervantes et al.   JOURNAL OF CLINICAL ONCOLOGY

A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis

(2012) Srdan Verstovsek et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impact of JAK2V617F mutation status, allele burden, and clearance after allogeneic stem cell transplantation for myelofibrosis

(2010) H. Alchalby et al.   BLOOD

Outcome of Transplantation for Myelofibrosis

(2009) Karen K. Ballen et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

(2009) N. Kroger et al.   BLOOD

Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor type

(2009) A Bacigalupo et al.   BONE MARROW TRANSPLANTATION